| Rivaroxaban versus warfarin in nonvalvular atrial fibrillation | New England Journal of Medicine | 2011 | 6.3K |
| Combined Nivolumab and Ipilimumab or Monotherapy in Untreated Melanoma | New England Journal of Medicine | 2015 | 5K |
| Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer | New England Journal of Medicine | 2006 | 4.1K |
| Cetuximab monotherapy and cetuximab plus irinotecan in irinotecan-refractory metastatic colorectal cancer | New England Journal of Medicine | 2004 | 4.1K |
| Nivolumab for Recurrent Squamous-Cell Carcinoma of the Head and Neck | New England Journal of Medicine | 2016 | 2.6K |
| Recommendations for human epidermal growth factor receptor 2 testing in breast cancer: American Society of Clinical Oncology/College of American Pathologists clinical practice guideline update | Journal of Clinical Oncology | 2013 | 2.6K |
| Metal-organic frameworks and self-assembled supramolecular coordination complexes: comparing and contrasting the design, synthesis, and functionality of metal-organic materials | Chemical Reviews | 2013 | 2.3K |
| Mortality results from a randomized prostate-cancer screening trial | New England Journal of Medicine | 2009 | 2.1K |
| Alpha emitter radium-223 and survival in metastatic prostate cancer | New England Journal of Medicine | 2013 | 2.1K |
| International uniform response criteria for multiple myeloma | Leukemia | 2006 | 2K |
| Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial | Lancet Oncology, The | 2015 | 1.9K |
| The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway | Annual Review of Biochemistry | 2010 | 1.9K |
| Compassionate Use of Remdesivir for Patients with Severe Covid-19 | New England Journal of Medicine | 2020 | 1.7K |
| Circulating tumor cells predict survival benefit from treatment in metastatic castration-resistant prostate cancer | Clinical Cancer Research | 2008 | 1.7K |
| Carboplatin dosage: prospective evaluation of a simple formula based on renal function | Journal of Clinical Oncology | 1989 | 1.5K |
| Diffusion-weighted MRI in the body: applications and challenges in oncology | American Journal of Roentgenology | 2007 | 1.5K |
| Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer (PROMIS): a paired validating confirmatory study | Lancet, The | 2017 | 1.5K |
| Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial | Lancet, The | 2014 | 1.5K |
| Ramucirumab plus paclitaxel versus placebo plus paclitaxel in patients with previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (RAINBOW): a double-blind, randomised phase 3 trial | Lancet Oncology, The | 2014 | 1.5K |
| Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress | Circulation | 2002 | 1.4K |
| Reporting standards for endovascular aortic aneurysm repair | Journal of Vascular Surgery | 2002 | 1.3K |
| Molecular imaging | Radiology | 2001 | 1.2K |
| TNM staging of foregut (neuro)endocrine tumors: a consensus proposal including a grading system | Virchows Archiv Fur Pathologische Anatomie Und Physiologie Und Fur Klinische Medizin | 2006 | 1.2K |
| Glioma Groups Based on 1p/19q, IDH, and TERT Promoter Mutations in Tumors | New England Journal of Medicine | 2015 | 1.2K |
| 2-year follow-up of trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer: a randomised controlled trial | Lancet, The | 2007 | 1.2K |
